Hydroxyzinum Espefa

Hydroxyzine Hydrochloride, the active ingredient in Hydroxyzinum Espefa, is a first‑generation antihistamine presented as an oral dosage form for oral use. It is employed to relieve allergic skin reactions, itching, anxiety and to provide sedation before or after surgical procedures.

GNH USA supplies Hydroxyzinum Espefa as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Hydroxyzine Hydrochloride acts on histamine‑mediated pathways and is indicated for several allergic and anxiety‑related conditions. - Urticaria and other allergic skin conditions: reduces itching and rash severity. - Pruritus of various origins: alleviates persistent itching. - Anxiety: provides calming effects in short‑term management. - Pre‑ or post‑operative sedation: induces mild sedation to facilitate procedures.

Hydroxyzine Hydrochloride may cause a range of adverse reactions, from mild to serious.

Common Side Effects: - Drowsiness: feeling unusually sleepy or fatigued. - Dry mouth: reduced salivation leading to a parched sensation. - Blurred vision: temporary difficulty focusing. - Constipation: slowed intestinal motility. - Headache: mild to moderate cranial pain. - Dizziness: sensation of light‑headedness or unsteadiness.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction with airway compromise. - Cardiac arrhythmia: irregular heart rhythm, especially in predisposed patients. - Seizures: rare occurrence of convulsive episodes. - Hepatic injury: signs of liver dysfunction such as jaundice. - Blood dyscrasias: abnormal blood counts including agranulocytosis. - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis.

When prescribing Hydroxyzine Hydrochloride, clinicians should consider several safety measures. - Sedation risk: evaluate patient’s ability to operate machinery or drive. - Elderly patients: start with lower doses due to increased sensitivity. - Glaucoma: avoid in patients with narrow‑angle glaucoma because of anticholinergic effects. - Concomitant CNS depressants: monitor for additive sedation. - Pregnancy and lactation: use only if benefit outweighs potential risk. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Hydroxyzine Hydrochloride can interact with other medicines, altering its safety profile.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): risk of severe hypotension and serotonin syndrome. - Central nervous system depressants (e.g., benzodiazepines, opioids): additive sedation and respiratory depression. - Alcohol: potentiates drowsiness and impairs coordination.

Moderate Interactions (Monitor Closely):\n- Anticholinergic agents: increased anticholinergic burden leading to confusion or urinary retention. - Antihypertensive drugs: possible enhancement of blood‑pressure‑lowering effects. - QT‑prolonging medications: potential for cardiac rhythm disturbances.